Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Circulation
|
May 15, 1996
Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans
W G Haynes, C J Ferro, K P O'Kane, et al.
QJM : Monthly Journal of the Association of Physicians
|
June 13, 2020
Response to: Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis-dependent chronic kidney disease
A H K Karangizi, D Chanouzas, A Fenton, et al.
Pediatric Nephrology (Berlin, Germany)
|
June 27, 2019
Assessing bone mineralisation in children with chronic kidney disease: what clinical and research tools are available?
A D Lalayiannis, N J Crabtree, M Fewtrell, et al.
British Journal of Clinical Pharmacology
|
November 14, 1997
The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction
C J Ferro, W G Haynes, N R Johnston, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 13, 2017
Premature coronary artery disease and early stage chronic kidney disease
A M Price, C J Ferro, M K Hayer, et al.
QJM : Monthly Journal of the Association of Physicians
|
April 14, 2016
Cytomegalovirus infection is associated with an increase in systolic blood pressure in older individuals
C Firth, R Harrison, S Ritchie, et al.
Cardiovascular Research
|
June 28, 2000
Endothelin receptor antagonism in patients with chronic heart failure
M P Love, C J Ferro, W G Haynes, et al.
Journal of Human Hypertension
|
May 20, 2011
Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors?
W E Moody, C D Chue, N G Inston, et al.
The British Journal of Radiology
|
February 25, 2015
Variability in cardiac MR measurement of left ventricular ejection fraction, volumes and mass in healthy adults: defining a significant change at 1 year
W E Moody, N C Edwards, C D Chue, et al.
British Journal of Clinical Pharmacology
|
October 6, 1999
Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man
D E Newby, D G Sciberras, C J Ferro, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Circulation
|
May 15, 1996
Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans
W G Haynes, C J Ferro, K P O'Kane, et al.
QJM : Monthly Journal of the Association of Physicians
|
June 13, 2020
Response to: Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis-dependent chronic kidney disease
A H K Karangizi, D Chanouzas, A Fenton, et al.
Pediatric Nephrology (Berlin, Germany)
|
June 27, 2019
Assessing bone mineralisation in children with chronic kidney disease: what clinical and research tools are available?
A D Lalayiannis, N J Crabtree, M Fewtrell, et al.
British Journal of Clinical Pharmacology
|
November 14, 1997
The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction
C J Ferro, W G Haynes, N R Johnston, et al.
QJM : Monthly Journal of the Association of Physicians
|
October 13, 2017
Premature coronary artery disease and early stage chronic kidney disease
A M Price, C J Ferro, M K Hayer, et al.
QJM : Monthly Journal of the Association of Physicians
|
April 14, 2016
Cytomegalovirus infection is associated with an increase in systolic blood pressure in older individuals
C Firth, R Harrison, S Ritchie, et al.
Cardiovascular Research
|
June 28, 2000
Endothelin receptor antagonism in patients with chronic heart failure
M P Love, C J Ferro, W G Haynes, et al.
Journal of Human Hypertension
|
May 20, 2011
Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors?
W E Moody, C D Chue, N G Inston, et al.
The British Journal of Radiology
|
February 25, 2015
Variability in cardiac MR measurement of left ventricular ejection fraction, volumes and mass in healthy adults: defining a significant change at 1 year
W E Moody, N C Edwards, C D Chue, et al.
British Journal of Clinical Pharmacology
|
October 6, 1999
Substance P-induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man
D E Newby, D G Sciberras, C J Ferro, et al.
Page
of 4